Skin News and Research

RSS

Viral infection of Leishmania leads to increased pathogenicity

A parasite and a virus may be teaming up in a way that increases the parasite's ability to harm humans, scientists at the University of Lausanne in Switzerland and Washington University School of Medicine in St. Louis report this week in Science.

11 Feb 2011

£160,000 award to devise anti-microbial collar to prevent bacterial infections associated with broken bones

Orthopaedic experts at The University of Nottingham are hoping to reduce the rate of infections that often occur in the pinning of broken bones by developing a special collar to counter dangerous microbes.

11 Feb 2011

New laser device fights cellulite from under the skin

Over 80% of women today live with the reality of having cellulite, making it one of the biggest cosmetic problems plaguing doctors and patients alike. And while there is everything from quick fixes to extensive invasive procedures to lessen this embarrassing condition, we all wait with anticipation for that modern, miracle treatment that permanently makes our dimpled skin vanish while allowing us to maintain our regular schedules.

10 Feb 2011

New rotary-powered device for bone marrow aspiration, biopsy yields superior samples with less pain

For many cancer patients, a bone marrow biopsy and/or aspiration is one of the most dreaded aspects of their diagnosis and treatment plan. The traditional method for gaining bone marrow involves grinding a needle by hand through a patient's skin and bone, and the procedure is often described as extremely painful.

10 Feb 2011

ALQAEM to release online blood glucose monitor in the M.E.N.A. regions

The Health Care Division of ALQAEM International FZE, the exclusive master distributor for the M.E.N.A. region of the UFIT noninvasive medical device created by Biosign Technologies Inc. of Canada, is pleased to announce that it has placed orders for delivery this quarter and will begin a limited release in March to those M.E.N.A. regions that recognize the CE Mark for medical device registration.

10 Feb 2011

Human-worm connection research provides insight into brain development, diseases

"Man is but a worm" was the title of a famous caricature of Darwin's ideas in Victorian England. Now, 120 years later, a molecular analysis of mysterious marine creatures unexpectedly reveals our cousins as worms, indeed.

10 Feb 2011

New study: No difference in contamination between physicians' long-, short-sleeved workwear

Governmental agencies in the United Kingdom recently instituted guidelines banning physicians' white coats and the wearing of long-sleeved garments to decrease the transmission of bacteria within hospitals due to the belief that cuffs of long-sleeved shirts carry more bacteria. However, a new study published today in the Journal of Hospital Medicine shows that after an eight-hour day, there is no difference in contamination of long- and short-sleeved shirts, or on the skin at the wearers' wrists.

10 Feb 2011

Scientists generate beating heart cells from skin cells of young patients with severe genetic heart defect

Using skin cells from young patients who have a severe genetic heart defect, Stanford University School of Medicine scientists have generated beating heart cells that carry the same genetic mutation. The newly created human heart cells - cardiomyocytes - allowed the researchers for the first time to examine and characterize the disorder at the cellular level.

10 Feb 2011

BD and UCLB enter agreement for development of new diagnostics for ovarian, breast cancer

UCL Business (UCLB), a wholly owned subsidiary of University College London (UCL), and BD (Becton, Dickinson and Company), a leading global medical technology company, announced today an agreement aimed at improving the early detection of ovarian and breast cancers to ultimately enable earlier and more effective treatment.

From BD (Becton, Dickinson and Company) 10 Feb 2011

Everolimus phase III study shows improved progression-free survival in patients with pNET

In an international Phase III randomized study, everolimus, an inhibitor of the mammalian target of rapamycin, has shown to dramatically improve progression-free survival for patients with advanced pancreatic neuroendocrine tumors, according to researchers from The University of Texas MD Anderson Cancer Center.

9 Feb 2011

Topical cream used to treat skin diseases activates two distinct neuronal signaling pathways

Scratching deep beneath the surface, a team of researchers from the University of California, San Diego School of Medicine and three South Korean institutions have identified two distinct neuronal signaling pathways activated by a topical cream used to treat a variety of skin diseases. One pathway produces the therapeutic benefit; the other induces severe itching as a side effect.

9 Feb 2011

NivaSonix receives USPTO notice of allowance for 'External Ultrasound Lipoplasty' patent

NivaSonix, LLC announced today the allowance by the U. S. Patent and Trademark Office (USPTO) of its core patent "External Ultrasound Lipoplasty". Nine additional U.S. and international patents are pending with additional patent filings in progress. The patent describes a technology that allows a new generation of non-invasive ultrasound therapy for both fat and wrinkle reduction targeted for patients worldwide.

9 Feb 2011

Rib-X commences Phase 2b trial to assess delafloxacin, linezolid, vancomycin for treatment of ABSSSI

Rib-X Pharmaceuticals, an antibiotics company with a broad development-stage pipeline, today announced the initiation of a Phase 2b clinical trial to evaluate delafloxacin, linezolid and vancomycin for the treatment of acute bacterial skin and skin structure infections, including infections caused by methicillin-resistant Staphylococcus aureus.

8 Feb 2011

Sun exposure reduces risk of multiple sclerosis: Study

A new Australian study has found that increased sun exposure and higher vitamin D levels may help to protect against the risk of developing multiple sclerosis (MS).

8 Feb 2011

Scientists develop low cost, nanometer-sized drug to treat chronic wounds

A low cost, nanometer-sized drug to treat chronic wounds, such as diabetic foot ulcers or burns, has been developed by a group of scientists from the Hebrew University of Jerusalem, Harvard Medical School and others in the U.S. and Japan.

8 Feb 2011

UK's first totally implantable hearing aid operation performed at Queen Alexandra Hospital

A woman from Portsmouth has received the UK's first totally implantable hearing aid thanks to the work of the South of England Cochlear Implant Centre (SOECIC), based at the University of Southampton.

8 Feb 2011

Tower announces formation of Cancer Support Network to provide high quality of care

As part of its commitment to providing the highest quality of care to the community, Tower Hematology Oncology Medical Group has announced the formation of Tower Oncology's Cancer Support Network.

8 Feb 2011

Researchers identify immune cell population that acts as body's border patrol with the outside world

So-called barrier sites -- the skin, gut, lung - limit the inner body's exposure to allergens, pollutants, viruses, bacteria, and parasites. Understanding how the immune system works in these external surfaces has implications for understanding such inflammatory diseases as asthma, psoriasis, IBD, and food allergies, all of which occur at the body's barriers.

8 Feb 2011

Dots to donate $91,086 for Cure's 'Girlfriends Giving Back' partnership program

Dots, LLC announced today that it will donate $91,086 to Susan G. Komen for the Cure to help fund ground-breaking research and life-saving community outreach projects through the "Girlfriends Giving Back" partnership program.

8 Feb 2011

Higher vitamin D levels and sun exposure linked to lower risk of multiple sclerosis

People who spend more time in the sun and those with higher vitamin D levels may be less likely to develop multiple sclerosis (MS), according to a study published in the February 8, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology. MS is a chronic disease of the brain and spinal cord, usually with recurrent flare-ups of symptoms. It is often preceded by a first episode (or event) of similar symptoms lasting days to weeks.

8 Feb 2011

Skin News and Research

Viral infection of Leishmania leads to increased pathogenicity

£160,000 award to devise anti-microbial collar to prevent bacterial infections associated with broken bones

New laser device fights cellulite from under the skin

New rotary-powered device for bone marrow aspiration, biopsy yields superior samples with less pain

ALQAEM to release online blood glucose monitor in the M.E.N.A. regions

Human-worm connection research provides insight into brain development, diseases

New study: No difference in contamination between physicians' long-, short-sleeved workwear

Scientists generate beating heart cells from skin cells of young patients with severe genetic heart defect

BD and UCLB enter agreement for development of new diagnostics for ovarian, breast cancer

Everolimus phase III study shows improved progression-free survival in patients with pNET

Topical cream used to treat skin diseases activates two distinct neuronal signaling pathways

NivaSonix receives USPTO notice of allowance for 'External Ultrasound Lipoplasty' patent

Rib-X commences Phase 2b trial to assess delafloxacin, linezolid, vancomycin for treatment of ABSSSI

Sun exposure reduces risk of multiple sclerosis: Study

Scientists develop low cost, nanometer-sized drug to treat chronic wounds

UK's first totally implantable hearing aid operation performed at Queen Alexandra Hospital

Tower announces formation of Cancer Support Network to provide high quality of care

Researchers identify immune cell population that acts as body's border patrol with the outside world

Dots to donate $91,086 for Cure's 'Girlfriends Giving Back' partnership program

Higher vitamin D levels and sun exposure linked to lower risk of multiple sclerosis

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News